Coleman Tim, Antoniak Marilyn, Britton John, Thornton Jim, Lewis Sarah, Watts Kim
Division of Primary Care, University of Nottingham, Queen's University Medical Centre, Nottingham NG7 2UH England.
BMC Health Serv Res. 2004 Nov 1;4(1):29. doi: 10.1186/1472-6963-4-29.
Smoking in pregnancy is a public health problem and effective methods for reducing this are required. Although nicotine replacement therapy (NRT) is effective for smoking cessation in non-pregnant people, there is no direct evidence concerning its effectiveness in pregnancy. Despite this, clinical guidelines recommend the cautious use of NRT during pregnancy. Randomised controlled trials are needed to determine the safety and efficacy of NRT when used by pregnant women for smoking cessation, but the feasibility of recruiting women to such trials is unknown. Consequently, in this study we aimed to determine i) the feasibility of recruiting women to a RCT of NRT in pregnancy as they attend hospital antenatal ultrasound examinations, ii) the proportion of such women who are eligible for and interested in trial enrollment and iii) research staff perceptions of how one method of trial recruitment could be improved.
During a one month period, all women attending for antenatal ultrasound examination in an English teaching hospital were asked to complete a questionnaire which determined their eligibility to enroll in a proposed placebo controlled randomised trial investigating the effectiveness of NRT in pregnancy. Women who were eligible to participate were asked whether they would do so and those who accepted enrollment were offered an appointment with a smoking cessation advisor.
Over 99% (851/858) of women agreed to complete a questionnaire about smoking habits whilst waiting for ultrasound examinations. 10.3% (88/851) of women attending for antenatal ultrasound fitted eligibility criteria for a proposed RCT of NRT in pregnancy, but only 3.6% [(31/851), 95% CI, 2.4 to 4.9%] indicated on the questionnaire that they would like to take part in a study involving randomisation to placebo or active patches. Researchers offered trial enrollment to 26 of these 31 women and 96% (25) accepted. Staff recruiting women believed that trial recruitment would be maximised if women attending the ultrasound department knew about trial recruitment before attending and greater staff resources were made available for this. It was also perceived that women generally under-reported the amount they smoked on questionnaires completed whilst waiting in ultrasound department areas.
It is feasible to recruit women for a trial of NRT in pregnancy as they wait for antenatal ultrasound examinations. Using similar recruitment methods, researchers can expect to recruit between 24 and 49 women per 1000 approached.
孕期吸烟是一个公共卫生问题,需要有效的解决方法。尽管尼古丁替代疗法(NRT)对非孕期人群戒烟有效,但尚无关于其在孕期有效性的直接证据。尽管如此,临床指南仍建议在孕期谨慎使用NRT。需要进行随机对照试验来确定孕妇使用NRT戒烟的安全性和有效性,但招募女性参与此类试验的可行性尚不清楚。因此,在本研究中,我们旨在确定:i)在孕妇进行医院产前超声检查时招募她们参与NRT孕期随机对照试验的可行性;ii)符合试验入组条件且有兴趣参与试验的此类女性的比例;iii)研究人员对如何改进一种试验招募方法的看法。
在一个月的时间里,要求一家英语教学医院所有前来进行产前超声检查的女性填写一份问卷,以确定她们是否有资格参与一项拟议的安慰剂对照随机试验,该试验旨在研究NRT在孕期的有效性。符合参与条件的女性被询问是否愿意参与,那些接受入组的女性会被安排与戒烟顾问预约。
超过99%(851/858)的女性同意在等待超声检查时填写一份关于吸烟习惯的问卷。前来进行产前超声检查的女性中有10.3%(88/851)符合拟议的孕期NRT随机对照试验的入组标准,但问卷上仅3.6%(31/851,95%置信区间,2.4%至4.9%)表示愿意参与一项涉及随机分配到安慰剂或活性贴片的研究。研究人员向这31名女性中的26名提供了试验入组机会,96%(25名)接受了。招募女性的工作人员认为,如果超声科的女性在前来之前就知道试验招募情况,并且为此提供更多的工作人员资源,试验招募人数将达到最大化。还感觉到,女性在超声科候诊区填写问卷时,通常会少报自己的吸烟量。
在孕妇等待产前超声检查时招募她们参与NRT孕期试验是可行的。采用类似的招募方法,研究人员预计每接触1000名女性可招募24至49名女性。